1 / 26

ICCS e-Newsletter CSI Spring 2013

ICCS e-Newsletter CSI Spring 2013. David A Westerman, MBBS FRACP FRCPA Department of Pathology Peter MacCallum Cancer Centre Melbourne, Australia. e-CSI - Clinical History:.

vanna-terry
Download Presentation

ICCS e-Newsletter CSI Spring 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ICCS e-Newsletter CSI Spring 2013 David A Westerman, MBBS FRACP FRCPA Department of Pathology Peter MacCallum Cancer Centre Melbourne, Australia

  2. e-CSI - Clinical History: • A 52 year Caucasian man presents with pancytopenia for investigation, and a previous history of “T cell lymphoma”.

  3. e-CSI - Peripheral Blood: • CBCNormal Range • WBC: 0.5 x 109/l (4.0 – 11.0) • RBC: 2.86 x 1012/l (4.5 – 6.5) • Hgb: 9.0 g/dl (13.0 – 18.0) • Hct: 27.0 % (40.0 – 54.0) • MCV: 95.0 fl (80.0 – 96.0) • MCH: 32.0 pg (27.0 – 32.0) • MCHC: 32.9 g/dl (31.0 – 35.0) • RDW: 17.2% (11.7 – 15.7) • Plts: 25 x 109/l (150 – 400)

  4. e-CSI - Peripheral Blood: • CBC Differential • Granulocytes: 75% • Lymphocytes: 9% • Monocytes: 11% • Eosinophils: 2%

  5. e-CSI - Clinical History: • Bone marrow aspirate and trephine biopsy were performed. • Flow cytometricimmunophenotyping was performed on the bone marrow aspirate and the results from selected 8-color tubes are provided for review.

  6. e-CSI - Flow Cytometric Studies: • Acquired FACS Canto II, analyzed with Kaluza

  7. e-CSI - Flow Cytometric Studies: Initial gating strategies excluded doublets and debris Further gating to include WBC’s and then a more “targeted” gated population based on an unusual CD45 vs SSC plot, in this case – “mononuclear gate”

  8. e-CSI - Flow Cytometric Studies: An expanded monocytic population is also identified with weak (but normal) CD4 expression (green) 56% of mononuclear cells gated are CD2+, while T cells account for only 4%

  9. e-CSI - Flow Cytometric Studies: CD2 vs CD3 allows separation of the NK cell population (black) and monocytes (green) in this case. Normal CD4+ and 8+ T cells can also be seen (mustard colour and blue)

  10. e-CSI - Flow Cytometric Studies: CD2+ and 16/56+ NK cells (black), monocytes in green, residual T cells in mustard and light blue

  11. e-CSI - Flow Cytometric Studies: NK cells are CD94+bright, 26+bright, 4-, 27+  Normal T cells

  12. e-CSI - Flow Cytometric Studies: • Normal NK plot expressions Normal expression of pooled normal donors NK cells are in black, CD4+T cells mustard, CD8+ T cells in blue

  13. e-CSI - Flow CytometricConclusion: • NK cells 56% of mononuclear gate expressing: CD2+, 3-, 4-, 5 partial, 7-, 8-, 16/56+, 26+ bright, 27-, 94+ bright, TCR αβ- & γδ- • Monocytes –normal expression compared to controls with this panel of markers but expanded in number

  14. e-CSI – cont. • Correlation with morphology and subsequently immunohistochemistry was performed

  15. e-CSI – morphology The aspirate quality was poor. A trephine touch is depicted showing numerous large, immature haematopoietic precursors

  16. e-CSI – morphology H & E section x 40 magnification

  17. e-CSI – morphology H & E section x 200 magnification; Effacement by an undifferentiated population of large blast-like cells

  18. e-CSI – morphology CD2 demonstrates a dominant positive population, including mitotic figures

  19. e-CSI – morphology CD3 shows cytoplasmic staining, in keeping with staining of CD3 epsilon chains of NK cells

  20. e-CSI – morphology TIA shows a significant positive population, while some granzyme positivity was also seen (not shown), in keeping with the cytotoxic function of NK cells

  21. e-CSI – morphology • EBV ISH is not a validated in our mercuric chloride fixed trephines, so was not tested • TP53 IHC (not shown) showed positivity in about 20% of cells • Insufficient material was available for cytogenetics • TCR gene rearrangement studies were polyclonal

  22. e-CSI – Diagnosis • Aggressive NK-cell leukaemia • Reactive monocytosis

  23. e-CSI – Aggressive NK-cell leukaemia • This is a rare disorder with a preponderance in Asian and South American populations, and young to middle aged • There is a strong association with EBV • Patients present with fever, cytopenias, constitutional symptoms, leukaemic cells, DIC, or haemophagocytic syndrome. Skin involvement is uncommon

  24. e-CSI – Aggressive NK-cell leukaemia • Morphologically: NK cells in this disorder vary from typical large granular lymphocyte morphology to atypical forms with folded nuclei, and nucleoli to frank blasts • The typical phenotype is CD2+ CD3- CD3ε+ CD56+ CD57- CD16+ CD11b+ • FAS ligand (CD95) is found on neoplastic cells, and also in the serum • T cell receptor genes are germline

  25. e-CSI – Aggressive NK-cell leukaemia • >90% cases are EBV positive • Karyotypic anomalies vary and include 11q, 6q, 17p deletions • The prognosis is poor and median survival measureable in just a few months • Typically the disease is refractory to aggressive chemotherapy

  26. e-CSI – References • Chan JKC, Jaffe ES, Ralfkiaer E et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4TH edition, pp276-277. • Dearden CE, Johnson R, Pettengell R et al. Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma). Br J Haematol 2011; 153, 451–485. • Kawa-Ha K, Ishihara S, Ninomiya T et al. CD3-negative lymphoproliferativedisease of granular lymphocytes containing Epstein-Barr viral DNA. J ClinInves 1989; 84: 51-55. • Kwong YL, The Diagnosis & management of extranodal NK/T cell lymphoma, nasal-type and aggreesive NK-cell leukemia. J ClinExpHematopath. 2011; 51: 21-27. • Suzuki R, Suzumiya J, NakamuraS et al.Aggressivenaturalkiller-cell leukemia revisited: largegranularlymphocyte leukemia of cytotoxicNK cells. Leukemia 2004; 18: 763–770.

More Related